Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| DME Capital Management, LP | 2.34M | $9.0M | 9.96% | +309.6K | 2026-03-31 |
| AIGH Capital Management LLC | 975.4K | $3.0M | 4.16% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 844.9K | $3.0M | 3.60% | -- | 2026-03-31 |
| Alyeska Investment Group, L.P. | 800.0K | $3.0M | 3.41% | -- | 2026-03-31 |
| Prosight Management, LP | 420.4K | $1.0M | 1.79% | -- | 2026-03-31 |
| CM Management, LLC | 375.0K | $1.0M | 1.60% | +25.0K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 233.4K | -- | 1.00% | +35.4K | 2026-03-31 |
| MARSHALL WACE, LLP | 225.8K | -- | 0.96% | +434 | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 139.9K | -- | 0.60% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 104.0K | -- | 0.44% | +37.1K | 2026-03-31 |
